Evidence map›Paper›PMID 40454399›Full record

ArticleBlood neoplasia2024

Saliva as a feasible alternative to blood for interrogation of somatic hematopoietic variants.

Eli M Soyfer, Jianhong C Heidmann, Gajalakshmi Ramanathan, Hellen Nguyen, Simran Bhardwaj, Jane H Chen, Yeowon Jung, Eshika Arora, Helen Huang, Lauren Chen and 6 more

Abstract read
In one paragraph

Article in Blood neoplasia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Eli M SoyferDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Jianhong C HeidmannDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Gajalakshmi RamanathanDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Hellen NguyenDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Simran BhardwajUniversity of New Mexico, Albuquerque, NM.
Jane H ChenDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Yeowon JungDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Eshika AroraDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Helen HuangDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Lauren ChenDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Aanya AminDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Eduard Mas MarinDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
W Lucas WadleyDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Hew Yeng LaiDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Nahid HaghighiDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.
Angela G FleischmanDivision of Hematology/Oncology, School of Medicine, University of California, Irvine, Irvine, CA.

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
CARCINOGENESIST32CA009054 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI EDINGER, AIMEE L, FRUMAN, DAVID ALEXANDER · 1985 to 2025
$8.6M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008620 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GOLDIN, ALAN L · 1999 to 2023
$8.1M
NCI NIH HHS P30 CA062203NCI NIH HHS T32 CA009054NIGMS NIH HHS T32 GM008620
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40454399
PMCPMC12082100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.